Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Weeks 4 to 12 (therapeutic phase) use a 2 to 5 percent concentration once daily, targeting active collagen stimulation and repair
Some biotech companies want to develop weight-loss drugs that, unlike semaglutide and tirzepatide, preserve muscle mass
Once bound, it triggers the PI3K/Akt/mTOR pathway, stimulating protein synthesis and muscle cell proliferation
While the peptide is not a weight-loss therapy, improving gut health may support metabolic function and indirectly influence weight regulation
US$ 21.02
US$ 24.25
US$ 20.35
